Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Egawa S, Takeda K, Fukuyama S, Motoi F, Sunamura M, Matsuno S. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28:235–40.

Article  PubMed  Google Scholar 

Li HY, Cui ZM, Chen J, Guo XZ, Li YY. Pancreatic cancer: diagnosis and treatments. Tumour Biol. 2015;36:1375–84.

Article  CAS  PubMed  Google Scholar 

Hanada K, Okazaki A, Hirano N, Izumi Y, Teraoka Y, Ikemoto J, Kanemitsu K, Hino F, Fukuda T, Yonehara S. Diagnostic strategies for early pancreatic cancer. J Gastroenterol. 2015;50:147–54.

Article  PubMed  Google Scholar 

Verma M. Pancreatic cancer biomarkers and their implication in cancer diagnosis and epidemiology. Cancers (Basel). 2010;2:1830–7.

Article  PubMed  Google Scholar 

Serban KA, Pratte KA, Bowler RP. Protein biomarkers for COPD outcomes. Chest. 2021;159:2244–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joshi GK, Deitz-McElyea S, Johnson M, Mali S, Korc M, Sardar R. Highly specific plasmonic biosensors for ultrasensitive microRNA detection in plasma from pancreatic cancer patients. Nano Lett. 2014;14:6955–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habartová L, Bunganič B, Tatarkovič M, Zavoral M, Vondroušová J, Syslová K, Setnička V. Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancer. Chirality. 2018;30:581–91.

Article  PubMed  Google Scholar 

Duarte IF, Diaz SO, Gil AM. NMR metabolomics of human blood and urine in disease research. J Pharm Biomed Anal. 2014;93:17–26.

Article  CAS  PubMed  Google Scholar 

Markley JL, Brüschweiler R, Edison AS, Eghbalnia HR, Powers R, Raftery D, Wishart DS. The future of NMR-based metabolomics. Curr Opin Biotechnol. 2017;43:34–40.

Article  CAS  PubMed  Google Scholar 

Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1–7.

Article  CAS  PubMed  Google Scholar 

Glimelius B, Hoffman K, Sjödén PO, Jacobsson G, Sellström H, Enander LK, Linné T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol. 1996;7:593–600.

Article  CAS  PubMed  Google Scholar 

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, et al. Pancreatic adenocarcinoma, Version 2.2017, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw. 2017;15:1028–61.

Goral V. Pancreatic Cancer: Pathogenesis and diagnosis. Asian Pac J Cancer Prev. 2015;16:5619–24.

Article  PubMed  Google Scholar 

Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, et al. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 2018;379:2395–406.

Article  CAS  PubMed  Google Scholar 

Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K, Niedergethmann M, Zülke C, Fahlke J, Arning MB, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310:1473–81.

Article  CAS  PubMed  Google Scholar 

Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304:1073–81.

Article  CAS  PubMed  Google Scholar 

Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, Faluyi O, O’Reilly DA, Cunningham D, Wadsley J, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389:1011–24.

Article  CAS  PubMed  Google Scholar 

Yarahmadi S, Abdolvahabi Z, Hesari Z, Tavakoli-Yaraki M, Yousefi Z, Seiri P, Hosseinkhani S, Nourbakhsh M. Inhibition of sirtuin 1 deacetylase by mir-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Gene. 2019;711:143939.

Article  CAS  PubMed  Google Scholar 

Shirian FI, Karimi M, Alipour M, Salami S, Nourbakhsh M, Nekufar S, Safari-Alighiarloo N, Tavakoli-Yaraki M. Beta hydroxybutyrate induces lung cancer cell death, mitochondrial impairment and oxidative stress in a long term glucose-restricted condition. Mol Biol Rep. 2024;51:567.

Article  CAS  PubMed  Google Scholar 

Malhotra V, Sawal A. Metabolic effects of Ketogenic diets and their utilization in obesity management: a systematic review. Cureus. 2023;15:e36720.

PubMed  PubMed Central  Google Scholar 

Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25:262–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta L, Khandelwal D, Kalra S, Gupta P, Dutta D, Aggarwal S. Ketogenic diet in endocrine disorders: current perspectives. J Postgrad Med. 2017;63:242–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Phinney SD, Bistrian BR, Wolfe RR, Blackburn GL. The human metabolic response to chronic ketosis without caloric restriction: physical and biochemical adaptation. Metabolism. 1983;32:757–68.

Article  CAS  PubMed  Google Scholar 

Phinney SD. Ketogenic diets and physical performance. Nutr Metab (Lond). 2004;1:2.

Article  PubMed  Google Scholar 

Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67:789–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gregory RM, Hamdan H, Torisky D, Akers J. A low-carbohydrate ketogenic diet combined with 6-weeks of crossfit training improves body composition and performance. Int J Sports Exerc Med. 2017;3:1–10.

Article  Google Scholar 

Wilson J, Lowery R. The ketogenic bible: the authoritative guide to ketosis. Simon and Schuster; 2017.

Valenzuela PL, Castillo-García A, Lucia A, Naclerio F. Effects of combining a ketogenic Diet with Resistance Training on Body Composition, Strength, and Mechanical Power in trained individuals: a narrative review. Nutrients. 2021;13(9):3083.

Reichard GA Jr., Owen OE, Haff AC, Paul P, Bortz WM. Ketone-body production and oxidation in fasting obese humans. J Clin Invest. 1974;53:508–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steinhauser ML, Olenchock BA, O’Keefe J, Lun M, Pierce KA, Lee H et al. The circulating metabolome of human starvation. JCI Insight. 2018;3(16):e121434.

Alharbi A, Al-Sowayan NS. The effect of ketogenic-diet on health. Food Nutr Sci. 2020;11:301–13.

CAS  Google Scholar 

Dong TA, Sandesara PB, Dhindsa DS, Mehta A, Arneson LC, Dollar AL, Taub PR, Sperling LS. Intermittent fasting: a Heart Healthy Dietary Pattern? Am J Med. 2020;133:901–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams MS, Turos E. The Chemistry of the ketogenic Diet: Updates and opportunities in Organic synthesis. Int J Mol Sci. 2021;22:5230.

Article  CAS  PubMed